研究参与手册的创新发展:在药物使用障碍的临床试验中加强招募和保留黑人个体的策略。

IF 2.5 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Health Equity Pub Date : 2025-08-22 eCollection Date: 2025-01-01 DOI:10.1177/24731242251362181
Geoffrey Obel, DeWanda Harris-Trimiar, Joshua S Elmore, Taryn L Mayes, Adrienne Mays, Angela Casey-Willingham, Srividya Vasu, Steven Shoptaw, Madhukar H Trivedi
{"title":"研究参与手册的创新发展:在药物使用障碍的临床试验中加强招募和保留黑人个体的策略。","authors":"Geoffrey Obel, DeWanda Harris-Trimiar, Joshua S Elmore, Taryn L Mayes, Adrienne Mays, Angela Casey-Willingham, Srividya Vasu, Steven Shoptaw, Madhukar H Trivedi","doi":"10.1177/24731242251362181","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The participation of Black individuals in clinical trials remains lower than that of other racial and ethnic groups. Substance abuse adds additional barriers to recruitment and retention. While significant attention has been devoted to identifying barriers to recruitment/retention, efforts have been largely unsuccessful in increasing the participation of Black individuals in clinical trials. This article details Phase 1 efforts to develop sustainable strategies to increase enrollment/recruitment of Black participants in clinical trials through an Innovative Development of Research Engagement Manual.</p><p><strong>Methods: </strong>Phase 1 involved a literature review and the establishment of an Expert Diversity Advisory Board, which identified barriers to Black individual participation in substance use disorder (SUD) research. Identified barriers included lack of awareness of research, mistrust, lack of comfort with research, lack of information, and time/resource constraints. Focus groups were conducted to assess the importance of the identified factors in 61 Black participants with SUD history.</p><p><strong>Results: </strong>Among the focus group participants, 37.7% indicated mistrust, 45.9% indicated a lack of knowledge, and 27.9% stated safety concerns as reasons for not engaging with researchers. They considered compensation, research benefits, study duration, privacy, safety, and side effects as vital information that informed their decisions on clinical trial participation. The focus groups identified financial incentives, potential treatment options, and potential for improved awareness about substance abuse treatment as factors that determine retention in a study.</p><p><strong>Conclusion: </strong>With barriers identified, future efforts will focus on qualitative assessments of focus group material and developing and evaluating the manual.</p>","PeriodicalId":36602,"journal":{"name":"Health Equity","volume":"9 1","pages":"387-396"},"PeriodicalIF":2.5000,"publicationDate":"2025-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12412388/pdf/","citationCount":"0","resultStr":"{\"title\":\"Innovative Development of Research Engagement Manual: Strategies to Enhance Recruitment and Retention of Black Individuals in Clinical Trials for Substance Use Disorders.\",\"authors\":\"Geoffrey Obel, DeWanda Harris-Trimiar, Joshua S Elmore, Taryn L Mayes, Adrienne Mays, Angela Casey-Willingham, Srividya Vasu, Steven Shoptaw, Madhukar H Trivedi\",\"doi\":\"10.1177/24731242251362181\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The participation of Black individuals in clinical trials remains lower than that of other racial and ethnic groups. Substance abuse adds additional barriers to recruitment and retention. While significant attention has been devoted to identifying barriers to recruitment/retention, efforts have been largely unsuccessful in increasing the participation of Black individuals in clinical trials. This article details Phase 1 efforts to develop sustainable strategies to increase enrollment/recruitment of Black participants in clinical trials through an Innovative Development of Research Engagement Manual.</p><p><strong>Methods: </strong>Phase 1 involved a literature review and the establishment of an Expert Diversity Advisory Board, which identified barriers to Black individual participation in substance use disorder (SUD) research. Identified barriers included lack of awareness of research, mistrust, lack of comfort with research, lack of information, and time/resource constraints. Focus groups were conducted to assess the importance of the identified factors in 61 Black participants with SUD history.</p><p><strong>Results: </strong>Among the focus group participants, 37.7% indicated mistrust, 45.9% indicated a lack of knowledge, and 27.9% stated safety concerns as reasons for not engaging with researchers. They considered compensation, research benefits, study duration, privacy, safety, and side effects as vital information that informed their decisions on clinical trial participation. The focus groups identified financial incentives, potential treatment options, and potential for improved awareness about substance abuse treatment as factors that determine retention in a study.</p><p><strong>Conclusion: </strong>With barriers identified, future efforts will focus on qualitative assessments of focus group material and developing and evaluating the manual.</p>\",\"PeriodicalId\":36602,\"journal\":{\"name\":\"Health Equity\",\"volume\":\"9 1\",\"pages\":\"387-396\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2025-08-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12412388/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Health Equity\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/24731242251362181\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health Equity","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/24731242251362181","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

摘要

背景:黑人个体在临床试验中的参与率仍然低于其他种族和族裔群体。滥用药物给招聘和留用增加了额外的障碍。虽然已经投入了大量的注意力来确定招募/保留的障碍,但在增加黑人个体参与临床试验方面的努力基本上是不成功的。本文详细介绍了通过创新发展研究参与手册制定可持续战略以增加临床试验中黑人参与者的注册/招募的第一阶段努力。方法:第一阶段包括文献综述和专家多样性咨询委员会的建立,该委员会确定了黑人参与物质使用障碍(SUD)研究的障碍。确定的障碍包括缺乏对研究的认识、不信任、对研究缺乏信心、缺乏信息以及时间/资源限制。对61名有SUD病史的黑人参与者进行焦点小组研究,以评估确定因素的重要性。结果:在焦点小组参与者中,37.7%的人表示不信任,45.9%的人表示缺乏知识,27.9%的人表示安全问题是不与研究人员接触的原因。他们认为报酬、研究收益、研究持续时间、隐私、安全性和副作用是决定是否参加临床试验的重要信息。焦点小组确定了经济激励,潜在的治疗方案,以及提高对药物滥用治疗的认识的潜力,作为决定研究保留的因素。结论:在确定障碍后,今后的工作将侧重于焦点小组材料的定性评估以及编写和评估手册。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Innovative Development of Research Engagement Manual: Strategies to Enhance Recruitment and Retention of Black Individuals in Clinical Trials for Substance Use Disorders.

Background: The participation of Black individuals in clinical trials remains lower than that of other racial and ethnic groups. Substance abuse adds additional barriers to recruitment and retention. While significant attention has been devoted to identifying barriers to recruitment/retention, efforts have been largely unsuccessful in increasing the participation of Black individuals in clinical trials. This article details Phase 1 efforts to develop sustainable strategies to increase enrollment/recruitment of Black participants in clinical trials through an Innovative Development of Research Engagement Manual.

Methods: Phase 1 involved a literature review and the establishment of an Expert Diversity Advisory Board, which identified barriers to Black individual participation in substance use disorder (SUD) research. Identified barriers included lack of awareness of research, mistrust, lack of comfort with research, lack of information, and time/resource constraints. Focus groups were conducted to assess the importance of the identified factors in 61 Black participants with SUD history.

Results: Among the focus group participants, 37.7% indicated mistrust, 45.9% indicated a lack of knowledge, and 27.9% stated safety concerns as reasons for not engaging with researchers. They considered compensation, research benefits, study duration, privacy, safety, and side effects as vital information that informed their decisions on clinical trial participation. The focus groups identified financial incentives, potential treatment options, and potential for improved awareness about substance abuse treatment as factors that determine retention in a study.

Conclusion: With barriers identified, future efforts will focus on qualitative assessments of focus group material and developing and evaluating the manual.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Health Equity
Health Equity Social Sciences-Health (social science)
CiteScore
3.80
自引率
3.70%
发文量
97
审稿时长
24 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信